Ferdinand von Prondzynski

DGAP-News: Epigenomics AG: Dr. Garces transitions to Company Advisor

Retrieved on: 
Wednesday, January 27, 2021
Epigenetics, Biology, Epigenomics AG, Ferdinand von Prondzynski, Epigenomics, Life sciences, DNA methylation

Berlin (Germany) and San Diego, CA (USA), January 27, 2021 - Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the "Company") announces that Dr. Jorge Garces, President and Chief Scientific Officer is resigning as an Executive Board member effective January 31, 2021.

Key Points: 
  • Berlin (Germany) and San Diego, CA (USA), January 27, 2021 - Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the "Company") announces that Dr. Jorge Garces, President and Chief Scientific Officer is resigning as an Executive Board member effective January 31, 2021.
  • Dr. Garces will transition to a Company Advisor role to assist the company through the end of 2021 with execution of strategic alternatives.
  • "Dr. Garces has been an important member of the Epigenomics management team and the Supervisory Board is very happy to have his help as an advisor as we look to plan on strategic options for the company", said Heino von Prondzynski Chairman of the Supervisory Board of Epigenomics.
  • Epigenomics is a molecular diagnostics company focused on blood-based detection of cancers using its proprietary DNA methylation biomarker technology.

Quotient Announces Appointment of Two New Board Members

Retrieved on: 
Thursday, July 23, 2020
Business, Brand management, Brands, Intellectual property law, Product management, Trademark, Quotient, Ferdinand von Prondzynski, Subsidiary, Marketing, Articles

Two of the Company's directors will be leaving the board and, effective September 1, 2020, two new directors will be joining.

Key Points: 
  • Two of the Company's directors will be leaving the board and, effective September 1, 2020, two new directors will be joining.
  • We are very fortunate to have them by our side, said Heino von Prondzynski, the Companys Chairman of the Board.
  • The Quotient logo, Quotient MosaiQ and MosaiQ are trademarks or registered trademarks of Quotient Limited or its subsidiaries in various jurisdictions.
  • The Quotient logo, Quotient MosaiQ and MosaiQ are trademarks or registered trademarks of Quotient Limited or its subsidiaries in various jurisdictions.